XactMice: Humanizing mouse bone marrow enables microenvironment reconstitution in a patient-derived xenograft model of head and neck cancer

J. J. Morton; G. Bird; S. B. Keysar; D. P. Astling; T. R. Lyons; R. T. Anderson; M. J. Glogowska; P. Estes; J. R. Eagles; P. N. Le; G. Gan; B. McGettigan; P. Fernandez; N. Padilla-Just; M. Varella-Garcia; J. I. Song; D. W. Bowles; P. Schedin; A. C. Tan; D. R. Roop; X. J. Wang; Y. Refaeli; A. Jimeno

doi:10.1038/onc.2015.94

XactMice: Humanizing mouse bone marrow enables microenvironment reconstitution in a patient-derived xenograft model of head and neck cancer

J. J. Morton, G. Bird, S. B. Keysar, D. P. Astling, T. R. Lyons, R. T. Anderson, M. J. Glogowska, P. Estes, J. R. Eagles, P. N. Le, G. Gan, B. McGettigan, P. Fernandez, N. Padilla-Just, M. Varella-Garcia, J. I. Song, D. W. Bowles, P. Schedin, A. C. Tan, D. R. RoopX. J. Wang, Y. Refaeli, A. Jimeno

Cell, Developmental, & Cancer Biology

Research output: Contribution to journal › Article

63 Scopus citations

Abstract

The limitations of cancer cell lines have led to the development of direct patient-derived xenograft models. However, the interplay between the implanted human cancer cells and recruited mouse stromal and immune cells alters the tumor microenvironment and limits the value of these models. To overcome these constraints, we have developed a technique to expand human hematopoietic stem and progenitor cells (HSPCs) and use them to reconstitute the radiation-depleted bone marrow of a NOD/SCID/IL2rg-/-(NSG) mouse on which a patient's tumor is then transplanted (XactMice). The human HSPCs produce immune cells that home into the tumor and help replicate its natural microenvironment. Despite previous passage on nude mice, the expression of epithelial, stromal and immune genes in XactMice tumors aligns more closely to that of the patient tumor than to those grown in non-humanized mice-an effect partially facilitated by human cytokines expressed by both the HSPC progeny and the tumor cells. The human immune and stromal cells produced in the XactMice can help recapitulate the microenvironment of an implanted xenograft, reverse the initial genetic drift seen after passage on non-humanized mice and provide a more accurate tumor model to guide patient treatment.

Original language	English (US)
Pages (from-to)	290-300
Number of pages	11
Journal	Oncogene
Volume	35
Issue number	3
DOIs	https://doi.org/10.1038/onc.2015.94
State	Published - Jan 21 2016

ASJC Scopus subject areas

Molecular Biology
Genetics
Cancer Research

Access to Document

10.1038/onc.2015.94

Fingerprint Dive into the research topics of 'XactMice: Humanizing mouse bone marrow enables microenvironment reconstitution in a patient-derived xenograft model of head and neck cancer'. Together they form a unique fingerprint.

Cite this

Morton, J. J., Bird, G., Keysar, S. B., Astling, D. P., Lyons, T. R., Anderson, R. T., Glogowska, M. J., Estes, P., Eagles, J. R., Le, P. N., Gan, G., McGettigan, B., Fernandez, P., Padilla-Just, N., Varella-Garcia, M., Song, J. I., Bowles, D. W., Schedin, P., Tan, A. C., ... Jimeno, A. (2016). XactMice: Humanizing mouse bone marrow enables microenvironment reconstitution in a patient-derived xenograft model of head and neck cancer. Oncogene, 35(3), 290-300. https://doi.org/10.1038/onc.2015.94

XactMice : Humanizing mouse bone marrow enables microenvironment reconstitution in a patient-derived xenograft model of head and neck cancer. / Morton, J. J.; Bird, G.; Keysar, S. B.; Astling, D. P.; Lyons, T. R.; Anderson, R. T.; Glogowska, M. J.; Estes, P.; Eagles, J. R.; Le, P. N.; Gan, G.; McGettigan, B.; Fernandez, P.; Padilla-Just, N.; Varella-Garcia, M.; Song, J. I.; Bowles, D. W.; Schedin, P.; Tan, A. C.; Roop, D. R.; Wang, X. J.; Refaeli, Y.; Jimeno, A.

In: Oncogene, Vol. 35, No. 3, 21.01.2016, p. 290-300.

Research output: Contribution to journal › Article

Morton, JJ, Bird, G, Keysar, SB, Astling, DP, Lyons, TR, Anderson, RT, Glogowska, MJ, Estes, P, Eagles, JR, Le, PN, Gan, G, McGettigan, B, Fernandez, P, Padilla-Just, N, Varella-Garcia, M, Song, JI, Bowles, DW, Schedin, P, Tan, AC, Roop, DR, Wang, XJ, Refaeli, Y & Jimeno, A 2016, 'XactMice: Humanizing mouse bone marrow enables microenvironment reconstitution in a patient-derived xenograft model of head and neck cancer', Oncogene, vol. 35, no. 3, pp. 290-300. https://doi.org/10.1038/onc.2015.94

Morton, J. J. ; Bird, G. ; Keysar, S. B. ; Astling, D. P. ; Lyons, T. R. ; Anderson, R. T. ; Glogowska, M. J. ; Estes, P. ; Eagles, J. R. ; Le, P. N. ; Gan, G. ; McGettigan, B. ; Fernandez, P. ; Padilla-Just, N. ; Varella-Garcia, M. ; Song, J. I. ; Bowles, D. W. ; Schedin, P. ; Tan, A. C. ; Roop, D. R. ; Wang, X. J. ; Refaeli, Y. ; Jimeno, A. / XactMice : Humanizing mouse bone marrow enables microenvironment reconstitution in a patient-derived xenograft model of head and neck cancer. In: Oncogene. 2016 ; Vol. 35, No. 3. pp. 290-300.

@article{d4e1b1fafa6c4285b7c6a71caffe188c,

title = "XactMice: Humanizing mouse bone marrow enables microenvironment reconstitution in a patient-derived xenograft model of head and neck cancer",

abstract = "The limitations of cancer cell lines have led to the development of direct patient-derived xenograft models. However, the interplay between the implanted human cancer cells and recruited mouse stromal and immune cells alters the tumor microenvironment and limits the value of these models. To overcome these constraints, we have developed a technique to expand human hematopoietic stem and progenitor cells (HSPCs) and use them to reconstitute the radiation-depleted bone marrow of a NOD/SCID/IL2rg-/-(NSG) mouse on which a patient's tumor is then transplanted (XactMice). The human HSPCs produce immune cells that home into the tumor and help replicate its natural microenvironment. Despite previous passage on nude mice, the expression of epithelial, stromal and immune genes in XactMice tumors aligns more closely to that of the patient tumor than to those grown in non-humanized mice-an effect partially facilitated by human cytokines expressed by both the HSPC progeny and the tumor cells. The human immune and stromal cells produced in the XactMice can help recapitulate the microenvironment of an implanted xenograft, reverse the initial genetic drift seen after passage on non-humanized mice and provide a more accurate tumor model to guide patient treatment.",

author = "Morton, {J. J.} and G. Bird and Keysar, {S. B.} and Astling, {D. P.} and Lyons, {T. R.} and Anderson, {R. T.} and Glogowska, {M. J.} and P. Estes and Eagles, {J. R.} and Le, {P. N.} and G. Gan and B. McGettigan and P. Fernandez and N. Padilla-Just and M. Varella-Garcia and Song, {J. I.} and Bowles, {D. W.} and P. Schedin and Tan, {A. C.} and Roop, {D. R.} and Wang, {X. J.} and Y. Refaeli and A. Jimeno",

year = "2016",

month = jan,

day = "21",

doi = "10.1038/onc.2015.94",

language = "English (US)",

volume = "35",

pages = "290--300",

journal = "Oncogene",

issn = "0950-9232",

publisher = "Nature Publishing Group",

number = "3",

}

TY - JOUR

T1 - XactMice

T2 - Humanizing mouse bone marrow enables microenvironment reconstitution in a patient-derived xenograft model of head and neck cancer

AU - Morton, J. J.

AU - Bird, G.

AU - Keysar, S. B.

AU - Astling, D. P.

AU - Lyons, T. R.

AU - Anderson, R. T.

AU - Glogowska, M. J.

AU - Estes, P.

AU - Eagles, J. R.

AU - Le, P. N.

AU - Gan, G.

AU - McGettigan, B.

AU - Fernandez, P.

AU - Padilla-Just, N.

AU - Varella-Garcia, M.

AU - Song, J. I.

AU - Bowles, D. W.

AU - Schedin, P.

AU - Tan, A. C.

AU - Roop, D. R.

AU - Wang, X. J.

AU - Refaeli, Y.

AU - Jimeno, A.

PY - 2016/1/21

Y1 - 2016/1/21

N2 - The limitations of cancer cell lines have led to the development of direct patient-derived xenograft models. However, the interplay between the implanted human cancer cells and recruited mouse stromal and immune cells alters the tumor microenvironment and limits the value of these models. To overcome these constraints, we have developed a technique to expand human hematopoietic stem and progenitor cells (HSPCs) and use them to reconstitute the radiation-depleted bone marrow of a NOD/SCID/IL2rg-/-(NSG) mouse on which a patient's tumor is then transplanted (XactMice). The human HSPCs produce immune cells that home into the tumor and help replicate its natural microenvironment. Despite previous passage on nude mice, the expression of epithelial, stromal and immune genes in XactMice tumors aligns more closely to that of the patient tumor than to those grown in non-humanized mice-an effect partially facilitated by human cytokines expressed by both the HSPC progeny and the tumor cells. The human immune and stromal cells produced in the XactMice can help recapitulate the microenvironment of an implanted xenograft, reverse the initial genetic drift seen after passage on non-humanized mice and provide a more accurate tumor model to guide patient treatment.

AB - The limitations of cancer cell lines have led to the development of direct patient-derived xenograft models. However, the interplay between the implanted human cancer cells and recruited mouse stromal and immune cells alters the tumor microenvironment and limits the value of these models. To overcome these constraints, we have developed a technique to expand human hematopoietic stem and progenitor cells (HSPCs) and use them to reconstitute the radiation-depleted bone marrow of a NOD/SCID/IL2rg-/-(NSG) mouse on which a patient's tumor is then transplanted (XactMice). The human HSPCs produce immune cells that home into the tumor and help replicate its natural microenvironment. Despite previous passage on nude mice, the expression of epithelial, stromal and immune genes in XactMice tumors aligns more closely to that of the patient tumor than to those grown in non-humanized mice-an effect partially facilitated by human cytokines expressed by both the HSPC progeny and the tumor cells. The human immune and stromal cells produced in the XactMice can help recapitulate the microenvironment of an implanted xenograft, reverse the initial genetic drift seen after passage on non-humanized mice and provide a more accurate tumor model to guide patient treatment.

UR - http://www.scopus.com/inward/record.url?scp=84955377769&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84955377769&partnerID=8YFLogxK

U2 - 10.1038/onc.2015.94

DO - 10.1038/onc.2015.94

M3 - Article

C2 - 25893296

AN - SCOPUS:84955377769

VL - 35

SP - 290

EP - 300

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 3

ER -